Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
Tel: |
010-010-52878169 15801002657 |
Email: |
sales@bjcomparison.com |
Products Intro: |
Product Name:(R)-3-cyclopentyl-3-(4-(7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile CAS:1236033-03-6 Purity:≥98% Package:100mg
|
Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
Tel: |
15374522761 |
Email: |
3003392093@qq.com |
Products Intro: |
Product Name:Ruxolitinib Impurity 4 CAS:1236033-03-6 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- manufacturers
|
| 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- Basic information | Uses |
Product Name: | 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- | Synonyms: | 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-;(3R)-3-cyclopentyl-3-[4-[7-(hydroxymethyl)pyrrolo[2,3-d]pyrimidin-4-yl]pyrazol-1-yl]propanenitrile;Ruxolitinib N-Methanol;Ruxolitinib Impurity 4;Ruxolitinib Impurity 11;Ruxolitinib Impurity 9;1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-;Ruxolitinib lmpurity3 | CAS: | 1236033-03-6 | MF: | C18H20N6O | MW: | 336.391 | EINECS: | | Product Categories: | | Mol File: | 1236033-03-6.mol | |
| 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- Chemical Properties |
Boiling point | 621.2±55.0 °C(Predicted) | density | 1.41±0.1 g/cm3(Predicted) | pka | 10.96±0.10(Predicted) |
| 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- Usage And Synthesis |
Uses | Ruxolitinib N-Methanol is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. | Uses | Ruxolitinib N-Methanol is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. |
| 1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- Preparation Products And Raw materials |
|